Morning Market Movers
October 02, 2014 at 09:44 AM EDT
Esperion Therapeutics (NASDAQ: ESPR) shares climbed 18.55% to $28.95 after the company announced positive top-line Phase 2b results for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.